From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis.
breakthrough mucormycosis
diagnosis
management
mucormycosis
zygomycosis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
received:
29
12
2023
revised:
29
01
2024
accepted:
30
01
2024
medline:
10
2
2024
pubmed:
10
2
2024
entrez:
10
2
2024
Statut:
epublish
Résumé
Mucormycosis is an infrequent but fatal illness that mainly affects patients with uncontrolled diabetes mellitus, diabetic ketoacidosis, solid and hematologic neoplasms, organ transplantation, chronic steroid intake, prolonged neutropenia, iron overload states, neonatal prematurity, severe malnutrition, and HIV. Many cases were reported across the world recently following the COVID-19 pandemic. Recent research has led to a better understanding of the pathogenesis of the disease, and global guidelines are now available for managing this serious infection. Herein, we comprehensively review the etiological agents, pathogenesis, clinical presentations, diagnosis, and management of mucormycosis.
Identifiants
pubmed: 38337830
pii: diagnostics14030314
doi: 10.3390/diagnostics14030314
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Indian Council of Medical Research
ID : Myco/9/3/2021-ECD-II